Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Das, JagabandhuMoquin, Robert V.
Pitt, Sidney
Zhang, Rosemary F.
Shen, Ding Ren
McIntyre, Kim W.
Gillooly, Kathleen M.
Doweyko, Arthur M.
Sack, John S.
Zhang, Hongjian
Kiefer, Susan E.
Kish, Kevin
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
Document Type
Journal ArticlePublication Date
2008-03-25
Metadata
Show full item recordAbstract
The synthesis and structure-activity relationships (SAR) of p38 alpha MAP kinase inhibitors based on a pyrazolo-pyrimidine scaffold are described. These studies led to the identification of compound 2x as a potent and selective inhibitor of p38 alpha MAP kinase with excellent cellular potency toward the inhibition of TNFalpha production. Compound 2x was highly efficacious in vivo in inhibiting TNFalpha production in an acute murine model of TNFalpha production. X-ray co-crystallography of a pyrazolo-pyrimidine analog 2b bound to unphosphorylated p38 alpha is also disclosed.Source
Bioorg Med Chem Lett. 2008 Apr 15;18(8):2652-7. Epub 2008 Mar 10. Link to article on publisher's siteDOI
10.1016/j.bmcl.2008.03.019Permanent Link to this Item
http://hdl.handle.net/20.500.14038/32917PubMed ID
18359226Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.bmcl.2008.03.019